ABC news.com 2013.09.16 20:49
By KAY JOHNSON and MATTHEW PERRONE Associated Press
U.S. health regulators have placed a ban on imported drugs from a factory
operated by India's largest pharmaceutical company, Ranbaxy Laboratories,
due to manufacturing and quality control problems.
The import alert, issued Friday by the Food and Drug Administration,
effectively stops imports of 11 drugs from Ranbaxy's Mohali factory in
DRUG, REGULATOR, BOMBAY, RUPEE, FACTORY, LABORATORY, Sklamberg, Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc., USA, India, United Kingdom, Japan